PUBLICATIONS

Computational Drug Discovery · University of Edinburgh

52 publications · 2002–2026

2026

01
  1. 052

2025

03
  1. 051
    DoggifAI: a transformer based approach for antibody caninisation

    Grabarczyk, D., Kocikowski, M., Parys, M., Houston, D. R., Hupp, T., Alfaro, J. A., & Cohen, S. B. (2025)

    ImmunoInformatics.Link ↗
  2. 050
    SCORCH2: A Generalized Heterogeneous Consensus Model for High-Enrichment Interaction-Based Virtual Screening

    Chen, L., Blay, V., Ballester, P. J., & Houston, D. R. (2025)

    Advanced Science, e08318.DOI ↗
  3. 049
    CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13

    Herasymenko, O., Silva, M., Abu-Saleh, A. A. A. A., Ahmad, A., Alvarado-Huayhuaz, J., Arce, O. E., ... & Schapira, M. (2025)

    Journal of Chemical Information and Modeling.DOI ↗

2024

02
  1. 048
    AutoDock-SS: AutoDock for Multiconformational Ligand-based Virtual Screening

    Ni, B., Wang, H., Khalaf, H. K. S., Blay, V. & Houston, D. R., 13 May 2024

    Journal of Chemical Information and Modeling. 64, 9, p. 3779-3789 11 p.Link ↗
  2. 047
    Revealing the Indispensable Role of the RFamide Functionality using a Novel Acid Labile Benzofuranone based Amine (ALBA) Linker

    Mudd, G., Hendrikse, M., Shave, S., Houston, D. R., Millar, R. P. & Auer, M., 2024

    Helvetica Chimica Acta. 107(4), e202300204.DOI ↗

2023

02
  1. 046
    From Intuition to AI: Evolution of Small Molecule Representations in Drug Discovery

    McGibbon, M., Shave, S., Dong, J., Gao, Y., Houston, D. R., Xie, J., Yang, Y., Schwaller, P. & Blay, V., 29 Nov 2023

    Briefings in bioinformatics. 25, 1, 13 p., bbad422.Link ↗
  2. 045
    OpenFEPOPS: A Python implementation of the FEPOPS molecular similarity technique

    Chen, Y-K., Houston, D. R., Auer, M. & Shave, S., 9 Nov 2023

    The Journal of Open Source Software. 8, 91, 5 p., 5763.Link ↗

2022

04
  1. 044
    Comparison of ATP-binding pockets and discovery of homologous recombination Inhibitors

    Blay, V., Gailiunaite, S., Lee, C-Y., Chang, H-Y., Hupp, T., Houston, D. R. & Chi, P., 15 Sept 2022

    Bioorganic and Medicinal Chemistry. 74, 116923.Link ↗
  2. 043
    SCORCH: Improving structure-based virtual screening with machine learning classifiers, data augmentation, and uncertainty estimation

    McGibbon, M., Money-Kyrle, S., Blay, V. & Houston, D. R., 25 Jul 2022

    Journal of Advanced Research.Link ↗
  3. 042
    Evidence that nuclear receptors are related to terpene synthases

    Houston, D. R., Hanna, J., Lathe, J. C., Hillier, S. & Lathe, R., 14 Mar 2022

    Journal of molecular endocrinology. p. 153-166Link ↗
  4. 041
    A 5-FU precursor designed to evade anabolic and catabolic drug pathways and activated by Pd chemistry in vitro and in vivo

    Adam, C., Bray, T., Perez-Lopez, A., Tan, E. H., Rubio Ruiz, B., Baillache, D., Houston, D. R., Salji, M. J., Leung, H. Y. & Unciti-Broceta, A., 13 Jan 2022

    Journal of Medicinal Chemistry. 65, 1, p. 552-561Link ↗

2021

02
  1. 040
    Modelling of Hepatitis E virus RNA-dependent RNA polymerase genotype 3 from a chronic patient and in silico interaction analysis by molecular docking with Ribavirin

    Cancela, F., Rendon Marin, S., Quintero-Gil, C., Houston, D. R., Gumbis, G., Panzera, Y., Arbiza, J., Mirazo, S. & Pérez, R., 3 Dec 2021

    Journal of Biomolecular Structure and Dynamics.Link ↗
  2. 039
    Bypassing the requirement for aminoacyl-tRNA by a cyclodipeptide synthase enzyme

    Harding, C. J., Sutherland, E., Hanna, J. G., Houston, D. R. & Czekster, C. M., 15 Jan 2021

    RSC Chemical Biology. 11 p.Link ↗

2020

02
  1. 038
    PRL3-DDX21 transcriptional control of endolysosomal genes restricts melanocyte stem cell differentiation

    Johansson, J., Marie, K. L., Lu, Y., Brombin, A., Santoriello, C., Zeng, Z., Zich, J., Gautier, P., von Kriegsheim, A., Brunsdon, H., Wheeler, A. P., Dreger, M., Houston, D. R., Dooley, C. M., Sims, A. H., Busch-Nentwich, E. M., Zon, L. I., Illingworth, R. & Patton, E. E., 10 Aug 2020

    Developmental Cell. 54, 3, p. 317-332.E9 16 p.Link ↗
  2. 037
    Recognition dynamics of cancer mutations on the ERp57-Tapasin interface

    Padariya, M., Kalathiya, U., Houston, D. R. & Alfaro, J. A., 20 Mar 2020

    Cancers. 12, 3, 20 p.Link ↗

2019

06
  1. 036
    Insights into the effects of cancer associated mutations at the UPF2 and ATP binding sites of NMD master regulator: UPF1

    Kalathiya, U., Padariya, M., Pawlicka, K., Verma, C. S., Houston, D., Hupp, T. & Alfaro, J. A., 11 Nov 2019

  2. 035
    Design of drug-like hepsin inhibitors against prostate cancer and kidney stones

    Blay, V., Houston, D., Li, M. C., P. Ho, S., Stoller, M. L., Hsieh, H-P. & Houston, D., 28 Sept 2019

    Acta Pharmaceutica Sinica B. 10, 7, p. 1309-1320Link ↗
  3. 034
    Lamin A molecular compression and sliding as mechanisms behind nucleoskeleton elasticity

    Makarov, A. A., Zou, J., Houston, D. R., Spanos, C., Solovyova, A. S., Cardenal-Peralta, C., Rappsilber, J. & Schirmer, E. C., 11 Jul 2019

    Nature Communications. 10, 1, 17 p., 3056.Link ↗
  4. 033
    An inter-subunit protein-peptide interface that stabilizes the specific activity and oligomerization of the AAA+ chaperone Reptin

    Coufalova, D., Remnant, L., Hernychova, L., Muller, P., Healy, A., Kannan, S., Vojtesek, B., Westwood, N., Verma, C. S., Vojtesek, B., Hupp, T. R. & Houston, D. R., 15 May 2019

    Journal of proteomics. 199, p. 89-101 13 p.Link ↗
  5. 032
    Intrinsic lipid binding activity of ATG16L1 supports efficient membrane anchoring and autophagy

    Dudley, L. J., G Cabodevilla, A., Makar, A. N., Sztacho, M., Michelberger, T., Marsh, J. A., Houston, D. R., Martens, S., Jiang, X. & Gammoh, N., 2 May 2019

    EMBO Journal. 38, 9, 16 p., e100554.Link ↗
  6. 031
    Oligopeptide signaling through TbGPR89 drives Trypanosome Quorum sensing

    Rojas, F., Silvester, E., Young, J., Milne, R., Tettey, M., Houston, D. R., Walkinshaw, M. D., Pérez-Pi, I., Auer, M., Denton, H., Smith, T. K., Thompson, J. & Matthews, K. R., 10 Jan 2019

    Cell. 176, 1-2, p. 306-317.e16 28 p.Link ↗

2018

04
  1. 030
    ALDH1 bio-activates nifuroxazide to eradicate ALDHHigh melanoma-initiating cells

    Sarvi, S., Crispin, R., Lu, Y., Zeng, L., Hurley, T. D., Houston, D. R., von Kriegsheim, A., Chen, C-H., Mochly-Rosen, D., Ranzani, M., Mathers, M. E., Xu, X., Xu, W., Adams, D. J., Carragher, N. O., Fujita, M., Schuchter, L., Unciti-Broceta, A., Brunton, V. G. & Patton, E. E., 20 Dec 2018

    Cell Chemical Biology. 25, 12, p. 1456-1469.e6 20 p.Link ↗
  2. 029
    Demonstration of the Anthelmintic Potency of Marimastat in the Heligmosomoides Polygyrus Rodent Modeling

    Robertson, E., Harcus, Y., Johnston, C. J. C., Page, A. P., Walkinshaw, M. D., Maizels, R. M. & Houston, D., 1 Dec 2018

    The journal of parasitology. 104, 6, p. 705-709 5 p.Link ↗
  3. 028
    Fatty-acylation target sequence in the ligand-binding domain of vertebrate steroid receptors demarcates evolution from estrogen-related receptors

    Lathe, R. & Houston, D., Nov 2018, In: Journal of Steroid Biochemistry and Molecular Biology. 184, p. 20-28 9 p.,

    Journal of Steroid Biochemistry and Molecular Biology. 184, p. 20-28 9 p.Link ↗
  4. 027
    Development of potent inhibitors of receptor tyrosine kinases by ligand-based drug design and target-biased phenotypic screening

    Myers, S., Temps, C., Houston, D., Brunton, V. G. & Unciti-Broceta, A., 21 Feb 2018

    Journal of Medicinal Chemistry. 61, 5, p. 2104-2110 7 p.Link ↗

2017

01
  1. 026
    Mono-substituted Hydrocarbon Diastereomer Combinations Reveal Stapled Peptides with High Structural Fidelity

    Mcwhinnie, F. S., Sepp, K., Wilson, C., Kunath, T., Hupp, T. R., Baker, T. S., Houston, D. R. & Hulme, A. N., 21 Dec 2017

    Chemistry - A European Journal.Link ↗

2016

03
  1. 025
    Inhibitors of leishmania mexicana phosphoglycerate mutase identified by virtual screening and verified by inhibition studies

    Fuad, F. A. A., Houston, D. R., Michels, P. A. M., Fothergill-Gilmore, L. A. & Walkinshaw, M. D., 1 Jul 2016

    Journal Sains Malaysiana. 45, 7, p. 1113-1120 8 p.Link ↗
  2. 024
    Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines that Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase

    Fraser, C., Dawson, J. C., Dowling, R., Houston, D. R., Weiss, J. T., Munro, A. F., Muir, M., Harrington, L., Webster, S. P., Frame, M. C., Brunton, V. G., Patton, E. E., Carragher, N. O. & Unciti-Broceta, A., 26 May 2016

    Journal of Medicinal Chemistry.Link ↗
  3. 023
    Novel triazolothiadiazines act as potent anticancer agents in liver cancer cells through Akt and ASK-1 proteins

    Aytaç, P. S., Durmaz, I., Houston, D. R., Çetin-Atalay, R. & Tozkoparan, B., 15 Feb 2016

    Bioorganic and Medicinal Chemistry. 24, 4, p. 858-872 15 p.Link ↗

2015

07
  1. 022
    Identification and activity of inhibitors of the essential nematode-specific metalloprotease DPY-31

    France, D. J., Stepek, G., Houston, D. R., Williams, L., McCormack, G., Walkinshaw, M. D. & Page, A. P., 15 Dec 2015

    Bioorganic & Medicinal Chemistry Letters. 25, 24, p. 5752-5755 4 p.Link ↗
  2. 021
    Hetero-trans-β-glucanase, an enzyme unique to Equisetum plants, functionalises cellulose

    Simmons, T. J., Mohler, K. E., Holland, C., Goubet, F., Franková, L., Houston, D. R., Hudson, A. D., Meulewaeter, F. & Fry, S. C., 1 Sept 2015

    The Plant Journal. 83, 5, p. 753-769 17 p.Link ↗
  3. 020
    Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance

    McNeil, E. M., Astell, K. R., Ritchie, A-M., Shave, S., Houston, D. R., Bakrania, P., Jones, H. M., Khurana, P., Wallace, C., Chapman, T., Wear, M. A., Walkinshaw, M. D., Saxty, B. & Melton, D. W., Jul 2015

    DNA Repair. 31, p. 19-28 10 p.Link ↗
  4. 019
    Development of a novel ligand that modulates the protein-protein interactions of the AAA+ superfamily oncoprotein reptin

    Healy, A. R., Houston, D. R., Remnant, L., Huart, A. S., Brychtova, V., Maslon, M. M., Meers, O., Muller, P., Krejci, A., Blackburn, E. A., Vojtesek, B., Hernychova, L., Walkinshaw, M. D., Westwood, N. J. & Hupp, T. R., 1 May 2015

    Chemical Science. 6, 5, p. 3109-3116 8 p.Link ↗
  5. 018
    Structure- and ligand-based virtual screening identifies new scaffolds for inhibitors of the oncoprotein MDM2

    Houston, D. R., Yen, L. H., Pettit, S. & Walkinshaw, M. D., 17 Apr 2015

    PLoS ONE. 10, 4, e0121424.Link ↗
  6. 017
    UFSRAT: Ultra-fast shape recognition with atom types -The discovery of novel bioactive small molecular scaffolds for FKBP12 and 11βHSD1

    Shave, S., Blackburn, E. A., Adie, J., Houston, D. R., Auer, M., Webster, S. P., Taylor, P. & Walkinshaw, M. D., 6 Feb 2015

    PLoS ONE. 10, 2, p. e0116570Link ↗
  7. 016
    Structural Basis for the Inverted Repeat Preferences of mariner Transposases

    Trubitsyna, M., Grey, H., Houston, D., Finnegan, D. & Richardson, J., 2015

    Journal of Biological Chemistry. 290, 21, p. 13531-13540Link ↗

2013

02
  1. 015
    Artemisinin resistance in rodent malaria - mutation in the AP2 adaptor μ-chain suggests involvement of endocytosis and membrane protein trafficking

    Henriques, G., Martinelli, A., Rodrigues, L., Modrzynska, K., Fawcett, R., Houston, D. R., Borges, S. T., d'Alessandro, U., Tinto, H., Karema, C., Hunt, P. & Cravo, P., 2013

    Malaria Journal. 12, 118Link ↗
  2. 014
    Consensus Docking: Improving the Reliability of Docking in a Virtual Screening Context

    Houston, D. R. & Walkinshaw, M. D., 2013

    Journal of Chemical Information and Modeling. 53, 2, p. 384-390 7 p.Link ↗

2012

01
  1. 013
    Raf1 Is a DCAF for the Rik1 DDB1-Like Protein and Has Separable Roles in siRNA Generation and Chromatin Modification

    Buscaino, A., White, S. A., Houston, D. R., Lejeune, E., Simmer, F., de Lima Alves, F., Diyora, P. T., Urano, T., Bayne, E., Rappsilber, J. & Allshire, R. C., Feb 2012

    PLoS Genetics. 8, 2, e1002499.Link ↗

2011

01
  1. 012

2006

01
  1. 011
    Identification and characterization of a protein-tyrosine phosphatase in Leishmania: Involvement in virulence

    Nascimento, M., Zhang, W. W., Ghosh, A., Houston, D. R., Berghuis, A. M., Olivier, M. & Matlashewski, G.,, 24 Nov 2006

    Journal of Biological Chemistry. 281, 47, p. 36257-36268 12 p.Link ↗

2005

02
  1. 010
    Crystal structure and binding properties of the Serratia marcescens chitin-binding protein CBP21

    Vaaje-Kolstad, G., Houston, D. R., Riemen, A. H. K., Eijsink, V. G. H. & Van Aalten, D. M. F.,, 25 Mar 2005

    Journal of Biological Chemistry. 280, 12, p. 11313-11319 7 p.Link ↗
  2. 009
    Specificity and affinity of natural product cyclopentapeptide inhibitors against A. fumigatus, human, and bacterial chitinases

    Rao, F. V., Houston, D. R., Boot, R. G., Aerts, J. M. F. G., Hodkinson, M., Adams, D. J., Shiomi, K., Omura, S. & Van Aalten, D. M. F.,, 1 Jan 2005

    Chemistry and Biology. 12, 1, p. 65-76 12 p.Link ↗

2004

03
  1. 008
    Structure-based exploration of cyclic dipeptide chitinase inhibitors

    Houston, D. R., Synstad, B., Eijsink, V. G. H., Stark, M. J. R., Eggleston, I. M. & Van Aalten, D. M. F.,, 4 Nov 2004

    Journal of Medicinal Chemistry. 47, 23, p. 5713-5720 8 p.Link ↗
  2. 007
    Interactions of a Family 18 Chitinase with the Designed Inhibitor HM508 and Its Degradation Product, Chitobiono-δ-lactone

    Vaaje-Kolstad, G., Vasella, A., Peter, M. G., Netter, C., Houston, D. R., Westereng, B., Synstad, B., Eijsink, V. G. H. & Van Aalten, D. M. F.,, 30 Jan 2004

    Journal of Biological Chemistry. 279, 5, p. 3612-3619 8 p.Link ↗
  3. 006
    Structure of the D142N mutant of the family 18 chitinase ChiB from Serratia marcescens and its complex with allosamidin

    Vaaje-Kolstad, G., Houston, D. R., Rao, F. V., Peter, M. G., Synstad, B., Van Aalten, D. M. F. & Eijsink, V. G. H.,, 14 Jan 2004

    Biochimica et Biophysica Acta - Proteins and Proteomics. 1696, 1, p. 103-111 9 p. Research output: Contribution to journal › Article › peer-reviewLink ↗

2003

02
  1. 005
    Structure and ligand-induced conformational change of the 39-kDa glycoprotein from human articular chondrocytes

    Houston, D. R., Recklies, A. D., Krupa, J. C. & Van Aalten, D. M. F.,, 8 Aug 2003

    Journal of Biological Chemistry. 278, 32, p. 30206-30212 7 p.Link ↗
  2. 004
    Crystal structures of allosamidin derivatives in complex with human macrophage chitinase

    Rao, F. V., Houston, D. R., Boot, R. G., Aerts, J. M. F. G., Sakuda, S. & Van Aalten, D. M. F.,, 30 May 2003

    Journal of Biological Chemistry. 278, 22, p. 20110-20116 7 p.Link ↗

2002

03
  1. 003
    The cyclic dipeptide CI-4 [cyclo-(L-Arg-D-Pro)] inhibits family 18 chitinases by structural mimicry of a reaction intermediate

    Houston, D. R., Eggleston, I., Synstad, B., Eijsink, V. G. H. & Van Aalten, D. M. F.,, 15 Nov 2002

    Biochemical Journal. 368, 1, p. 23-27 5 p.Link ↗
  2. 002
    Structure of human chitotriosidase: Implications for specific inhibitor design and function of mammalian chitinase-like lectins

    Fusetti, F., Von Moeller, H., Houston, D., Rozeboom, H. J., Dijkstra, B. W., Boot, R. G., Aerts, J. M. F. G. & Van Aalten, D. M. F., 12 Jul 2002

    Journal of Biological Chemistry. 277, 28, p. 25537-25544 8 p.Link ↗
  3. 001
    High-resolution structures of a chitinase complexed with natural product cyclopentapeptide inhibitors: Mimicry of carbohydrate substrate

    Houston, D. R., Shiomi, K., Arai, N., Omura, S., Peter, M. G., Turberg, A., Synstad, B., Eijsink, V. G. H. & Van Aalten, D. M. F., 9 Jul 2002

    Proceedings of the National Academy of Sciences (PNAS). 99, 14, p. 9127-9132 6 p.Link ↗